Genmab A/S
GMAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $482,000 | $2,680,559 | $1,657,829 | $445,444 |
| Dep. & Amort. | $18,000 | $101,392 | $108,710 | $12,985 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $34,000 | $209,122 | $169,860 | $20,458 |
| Change in WC | $2,000 | -$665,387 | $509,579 | $15,964 |
| Other Non-Cash | $0 | -$1,932,791 | -$495,990 | -$168,414 |
| Operating Cash Flow | $536,000 | $392,895 | $1,949,987 | $326,437 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,000 | -$63,370 | -$81,533 | -$12,160 |
| Net Acquisitions | $0 | $0 | $0 | $125,709 |
| Inv. Purchases | -$387,000 | -$1,901,106 | -$1,848,071 | -$131,828 |
| Inv. Sales/Matur. | $335,000 | $2,129,239 | $1,759,744 | $147,085 |
| Other Inv. Act. | $0 | $0 | -$122,299 | -$14,826 |
| Investing Cash Flow | -$54,000 | $164,763 | -$292,158 | $113,980 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5,000 | -$25,348 | -$13,589 | $616 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$24,000 | -$2,572,830 | -$562,482 | $39,819 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,000 | $25,348 | $487,744 | $244 |
| Financing Cash Flow | -$21,000 | -$2,572,830 | -$88,327 | $40,679 |
| Forex Effect | $4,000 | -$31,685 | $54,355 | -$55,658 |
| Net Chg. in Cash | $465,000 | -$2,046,857 | $1,623,857 | $425,438 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,296,000 | $10,259,635 | $9,376,244 | $949,917 |
| End Cash | $1,761,000 | $8,212,778 | $11,000,101 | $1,375,356 |
| Free Cash Flow | $534,000 | $329,525 | $1,746,156 | $299,452 |